Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

AI-Based Hamstring Injury Risk Analysis and Effects of the FUNBALL Program

10 de junio de 2026 actualizado por: Yeditepe University

AI-Based Hamstring Injury Risk Analysis and the Effects of the FUNBALL Program on Physical Performance and Cognitive Function in Professional Football Players

This study investigates hamstring injury risk in football players using artificial intelligence-based motion analysis (OpenPose) and evaluates the effects of a targeted exercise intervention (FUNBALL). Hamstring risk is assessed during a 30-m sprint using sagittal-plane video analysis, and players classified as medium or high risk receive a four-month FUNBALL program. A pre-post intervention design is employed, with sprint performance, agility, balance, jumping ability, kicking power, and cognitive function assessed using standardized field and cognitive tests.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

Before the implementation of the FUNBALL program, artificial intelligence (OpenPose) based hamstring risk analysis and 30-meter sprint test, 505 agility and direction change test, modified star balance test, 5-point jump test, maximum shot distance test and cognition tests will be applied as pre-tests (18,19). AI risk analysis will be done by examining video (30 frame rate) captured with a phone camera (iPhone 14 Pro) from the sagittal (side) plane during the 240 m sprint test. The camera will be positioned 15 meters from the level of the middle of the 30-meter sprint test with the help of a tripod. It will follow the participant's run for 30 meters in motion. The football player will be asked to do a 30 m sprint with 3 repetitions and the average of 3 repetitions will be taken as a basis. According to the artificial intelligence risk analysis, the FUNBALL program will be applied to medium and high risk groups for 4 months. At the end of the Middle Program, the same parameters will be re-evaluated. Hamstring risk analysis and speed parameter will be evaluated with 30 meter sprint test, agility parameter 505 with direction change and agility test, cognition parameter with color word stroop test, n-back test and digit span test, balance and proprioception parameter with modified star balance test, jump parameter with 5-point jump test, and power parameter with maximum shot distance test.

Tipo de estudio

Intervencionista

Inscripción (Actual)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Büyükçekmece
      • Istanbul, Büyükçekmece, Turquía (Türkiye), 34537
        • Istanbulspor Ömer Sarıalioglu Football Team Facilitu

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • To be a professional football player between the ages of 18-35.
  • Not having a history of ligament, joint, bone, muscle or tendon injury that requires at least 2 months away from the field in the last 6 months.
  • Not having an active disability.
  • To have verbal and written communication skills who accept to participate in the study voluntarily and to perform exercise applications.

Exclusion Criteria:

  • Presence of an active disability
  • Having a history of ligament, joint, bone, muscle or tendon injury that requires at least 2 months away from the field in the last 6 months.
  • Vestibular or disconnected vision problems
  • History of cancer
  • Illiteracy
  • Mental and cognitive disorders that may affect communication

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: FUNBALL Intervention Arm
The FUNBALL Prevention Program is an evidence-based injury prevention exercise program described in the literature. The program was developed by Obertinca et al. and has been shown to reduce thigh muscle injury incidence by approximately 38% in football players. In the present study, the FUNBALL program is implemented as a structured training intervention aimed at reducing hamstring injury risk.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of Participants Classified as High Hamstring Injury Risk by OpenPose-Based Biomechanical Analysis
Periodo de tiempo: Baseline (Day 0) and post-intervention (Week 12)
Outcome measure: Number of participants classified as high hamstring injury risk. Assessment tool: OpenPose-based biomechanical motion analysis of a 30-meter sprint. Classification is based on hip flexion angle, knee extension angle, and terminal swing phase mechanics. Unit of measure: Number of participants classified as high risk.
Baseline (Day 0) and post-intervention (Week 12)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
505 COD Agility Test
Periodo de tiempo: Baseline (Day 0) and post-intervention (Week 12)
The 505 Change of Direction (COD) test is a widely used field-based assessment designed to evaluate an athlete's ability to decelerate, rapidly change direction, and re-accelerate over a short distance. The players are going to sprint forward 10 m, perform a 180-degree turn off a designated foot at the 5-m mark, and sprint back as quickly as possible, with total time is going to record using electronic timing gates or a stopwatch.
Baseline (Day 0) and post-intervention (Week 12)
Number of Players With Elevated Hamstring Injury Risk During Sprint Testing
Periodo de tiempo: Baseline (Day 0) and post-intervention (Week 12)
The primary outcome will be the number of players identified with elevated hamstring injury risk during a 30-m sprint test, assessed using an artificial intelligence-based movement analysis.
Baseline (Day 0) and post-intervention (Week 12)
N-Back Task Accuracy (%)
Periodo de tiempo: Baseline (Day 0) and Post-Intervention (Week 12)
Working memory performance assessed using a computerized N-Back task and reported as percentage accuracy (%).
Baseline (Day 0) and Post-Intervention (Week 12)
Digit Span Total Score
Periodo de tiempo: Baseline (Day 0) and Post Intervention (Week 12)
Total number of correctly recalled digits during a computerized Digit Span task.
Baseline (Day 0) and Post Intervention (Week 12)
Composite Reach Distance in Modified Star Excursion Balance Test
Periodo de tiempo: Baseline ( Day 0) and Post-Intervention (Week 12)
Composite normalized reach distance during the Modified Star Excursion Balance Test.
Baseline ( Day 0) and Post-Intervention (Week 12)
Horizontal Distance in Multiple Five Bounds Test
Periodo de tiempo: Baseline (Day 0) and Post-Intervention (Week 12)
Horizontal distance achieved during the Multiple Five Bounds Test assessing horizontal power.
Baseline (Day 0) and Post-Intervention (Week 12)
Maximal Soccer Ball Kicking Distance
Periodo de tiempo: Baseline (Day 0) and Post-Intervention (Week 12)
Maximum horizontal distance of a soccer ball following a maximal instep kick.
Baseline (Day 0) and Post-Intervention (Week 12)
Stroop Reaction Time
Periodo de tiempo: Baseline (Day 0) and Week 12
Mean reaction time during incongruent trials of a computerized Stroop task.
Baseline (Day 0) and Week 12

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Elif Tuğçe t Çil Sertöz, Asst. Prof. Dr., Yeditepe University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de febrero de 2026

Finalización primaria (Actual)

25 de abril de 2026

Finalización del estudio (Actual)

25 de abril de 2026

Fechas de registro del estudio

Enviado por primera vez

29 de diciembre de 2025

Primero enviado que cumplió con los criterios de control de calidad

10 de junio de 2026

Publicado por primera vez (Actual)

16 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Yeditepe U1

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Marco de tiempo para compartir IPD

January 2026-January 2027

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF
  • CÓDIGO_ANALÍTICO
  • RSC

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir